• EMVision's Share Purchase Plan (SPP) has received applications exceeding the maximum $2 million
• The SPP will be closed early on 21 October 2025 to minimize scale-back of applications
• A revised timetable for the SPP has been provided

EMVision Medical Devices Limited (ASX:EMV) has announced that the Share Purchase Plan (SPP), which was announced on 17 September 2025 and opened on 29 September, has received applications in excess of the maximum SPP of $2 million. In accordance with the terms of the SPP, the Company has determined to close the SPP early to minimise the scale back of applications. The new effective closure date for the SPP is 5:00pm (AEDT) on Tuesday, 21 October 2025 (Revised Closing Date). EMVision advises that any applications received after the Revised Closing Date will not be accepted under the SPP and those application monies will be returned in full to the applicant in accordance with the terms of the SPP. EMVision will undertake a scale-back of applications received prior to the Revised Closing Date. A revised timetable for the SPP has been provided, with key dates including the Settlement of New Shares issued under the Placement on 23 September 2025, Allotment of New Shares issued under the Placement on 24 September 2025, and Announcement of Results of SPP on 30 October 2025.